Gain Therapeutics (GANX) Assets (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly Assets of $18.7 million for Q1 2026, up 61.2% year-over-year from $11.6 million in Q1 2025, and down 17.88% quarter-over-quarter from $22.8 million in Q4 2025.
Gain Therapeutics (GANX) Assets (2020 - 2026) Analysis & Trends
Gain Therapeutics' Assets history runs 7 years deep, the most recent figure standing at $18.7 million for Q1 2026.
- In Q1 2026, Assets rose 61.2% year-over-year to $18.7 million; the TTM figure through Mar 2026 stood at $18.7 million (up 61.2% YoY), while the FY2025 annual figure was $22.8 million, up 88.22% from the prior year.
- Assets for Q1 2026 stood at $18.7 million, down from $22.8 million in the prior quarter.
- The five-year high for Assets was $37.6 million in Q1 2022, with the low at $9.8 million in Q2 2025.
- The 5-year median for Assets is $18.6 million (2023), against an average of $19.3 million.
- The sharpest annual moves came in 2023 and 2025: Assets plunged 50.23% in 2023, then surged 88.22% in 2025.
- Gain Therapeutics' Assets stood at $24.1 million in 2022, then declined by 22.78% to $18.6 million in 2023, then slumped by 34.85% to $12.1 million in 2024, then soared by 88.22% to $22.8 million in 2025, then decreased by 17.88% to $18.7 million in 2026.
- Business Quant data shows GANX's Assets at $18.7 million in Q1 2026, $22.8 million in Q4 2025, and $11.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Gain Therapeutics | 85.12 Mn | 85.12 Mn | - | 15.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.42 Mn |
| Mar 31, 2026 | 18.74 Mn |
| Dec 31, 2025 | 22.82 Mn |
| Sep 30, 2025 | 10.97 Mn |
| Jun 30, 2025 | 9.83 Mn |
| Mar 31, 2025 | 11.62 Mn |
| Dec 31, 2024 | 12.12 Mn |
| Sep 30, 2024 | 14.37 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 14.58 Mn |
| Dec 31, 2023 | 18.61 Mn |
| Sep 30, 2023 | 14.10 Mn |
| Jun 30, 2023 | 18.26 Mn |
| Mar 31, 2023 | 21.32 Mn |
| Dec 31, 2022 | 24.10 Mn |
| Sep 30, 2022 | 28.33 Mn |
| Jun 30, 2022 | 31.89 Mn |
| Mar 31, 2022 | 37.60 Mn |
| Dec 31, 2021 | 38.99 Mn |
| Sep 30, 2021 | 42.56 Mn |